Literature DB >> 7498577

Leber's hereditary optic neuropathy: implications of the sex ratio for linkage studies in families with the 3460 ND1 mutation.

G C Black1, I W Craig, R J Oostra, S Norby, T Rosenberg, K Morten, A Laborde, J Poulton.   

Abstract

Leber's hereditary optic neuropathy (LHON), which is associated with mutations in mitochondrial DNA (mtDNA), is commoner in males than females. A study of over 30 LHON families with a mutation at position 3460 of mtDNA demonstrates a significantly decreased male excess from that generally quoted, with evidence for a marked bias in the ascertainment of males over females. This has implications for the analysis of those factors which give rise to the male bias.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498577     DOI: 10.1038/eye.1995.117

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  4 in total

1.  No evidence for 'skewed' inactivation of the X-chromosome as cause of Leber's hereditary optic neuropathy in female carriers.

Authors:  R J Oostra; S Kemp; P A Bolhuis; E M Bleeker-Wagemakers
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

2.  A gene for X-linked optic atrophy is closely linked to the Xp11.4-Xp11.2 region of the X chromosome.

Authors:  J J Assink; N T Tijmes; J B ten Brink; R J Oostra; F C Riemslag; P T de Jong; A A Bergen
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

3.  Leber's hereditary optic neuropathy: heteroplasmy is likely to be significant in the expression of LHON in families with the 3460 ND1 mutation.

Authors:  G C Black; K Morten; A Laborde; J Poulton
Journal:  Br J Ophthalmol       Date:  1996-10       Impact factor: 4.638

4.  Genetic investigation of 211 Chinese families expands the mutational and phenotypical spectra of hereditary retinopathy genes through targeted sequencing technology.

Authors:  Zhouxian Bai; Yanchuan Xie; Lina Liu; Jingzhi Shao; Yuying Liu; Xiangdong Kong
Journal:  BMC Med Genomics       Date:  2021-03-29       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.